BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 664118)

  • 21. Metabolism of hydroxyethylrutosides (HR): metabolism of [14C]-HR in man.
    Hackett AM; Griffiths LA; Luyckx AS; van Cauwenberge H
    Arzneimittelforschung; 1976; 26(5):925-8. PubMed ID: 989368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protective effects of O-(beta-hydroxyethyl)-rutoside on cis-platinum-induced acute renal failure in the rat.
    Dobyan DC; Bull JM; Strebel FR; Sunderland BA; Bulger RE
    Lab Invest; 1986 Nov; 55(5):557-63. PubMed ID: 3773477
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of O-(beta-hydroxyethyl)-rutoside on the glucose metabolism of cultured human varicose saphenous veins.
    Matagne D; Gilles R
    Arch Int Physiol Biochim; 1977 Feb; 85(1):133-8. PubMed ID: 68718
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of inhibition of prostaglandin synthesis on microvascular haemostasis and macromolecular leakage.
    Arfors KE; Arturson G; Bergqvist D; Svensjö E
    Thromb Res; 1976 Mar; 8(3):393-402. PubMed ID: 1265710
    [No Abstract]   [Full Text] [Related]  

  • 25. o-(beta-Hydroxyethyl)-rutoside-mediated protection of renal injury associated with cis-diamminedichloroplatinum(II)/hyperthermia treatment.
    Bull JM; Strebel FR; Sunderland BA; Bulger RE; Edwards M; Siddik ZH; Newman RA
    Cancer Res; 1988 Apr; 48(8):2239-44. PubMed ID: 3349489
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Capillary resistance raising action of Venoruton. Experimental data on the therapeutic effects of Venoruton].
    Gábor M
    Acta Pharm Hung; 1983 May; 53(3):115-20. PubMed ID: 6880764
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effect of large doses of a flavonoid O-(betahydroxyethyl)-rutoside on some aspects of venous circulation].
    Forconi S; Guerrini M
    Clin Ter; 1977 Feb; 80(3):229-55. PubMed ID: 852233
    [No Abstract]   [Full Text] [Related]  

  • 28. A double-blind trial of O-(beta-hydroxyethyl)-rutoside in patients with chronic venous insufficiency.
    Bergqvist D; Hallböök T; Lindblad B; Lindhagen A
    Vasa; 1981; 10(3):253-60. PubMed ID: 7025500
    [No Abstract]   [Full Text] [Related]  

  • 29. The effect of O-(beta-hydroxyethyl)-rutosides (HR) on the skin capillary resistance of rats.
    Gábor M
    Arzneimittelforschung; 1981; 31(3):442-5. PubMed ID: 7194669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The hamster cheek pouch as a model in microcirculation research.
    Svensjö E
    Eur Respir J Suppl; 1990 Dec; 12():595s-600s; discussion 600s-601s. PubMed ID: 2076153
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rutoside and the X-ray induced damage in jejunal mucosa of mouse.
    Rao KR; Fritz-Niggli H
    Strahlentherapie; 1984 Oct; 160(10):624-6. PubMed ID: 6388050
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of oral administration of purified micronized flavonoid fraction on increased microvascular permeability induced by various agents and on ischemia/reperfusion in the hamster cheek pouch.
    Bouskela E; Donyo KA
    Angiology; 1997 May; 48(5):391-9. PubMed ID: 9158383
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Studies in animal experiments on determination of blood and organ levels of o-(beta-hydroxyethyl)-rutosides (HR) after i.p. administration (author's transl)].
    Reinartz G; Wurst F
    Arzneimittelforschung; 1980; 30(4):657-9. PubMed ID: 7190409
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analgesic effect of O-(beta-hydroxy ethyl)rutoside in mice.
    Ramaswamy S; Pillai NP; Gopalakrishnan V; Parmar NS; Ghosh MN
    Indian J Exp Biol; 1985 Apr; 23(4):219-20. PubMed ID: 4077117
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of 0-/-B-hydroxyethyl/rutoside on platelet function and thrombus formation in rat mesenteric vessels.
    Krupiński K; Breddin HK; Giedrojć J; Bodzenta-Lukaszyk A; Bielawiec M
    Mater Med Pol; 1995; 27(2):39-42. PubMed ID: 8935187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prevention of radiation-induced skin reactions in breast cancer].
    Pischnamazzadeh M
    Strahlentherapie; 1983 Jan; 159(1):9-12. PubMed ID: 6340249
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The bioflavonoid O-(beta-hydroxyethyl)-rutoside affects the cerebral metabolism and the permeability of the blood-brain barrier in the rat.
    Saija A; Princi P; De Pasquale R; Costa G
    Pharmacol Res; 1990; 22 Suppl 1():69-70. PubMed ID: 2284253
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of O-(beta-hydroxyethyl)-rutosides (HR) and indomethacin on transcapillary macromolecular transport and prostaglandins following scalding injury.
    Arturson G; Jonsson CE
    Bibl Anat; 1973; 12():465-70. PubMed ID: 4208231
    [No Abstract]   [Full Text] [Related]  

  • 39. Dimensions of postcapillary venules sensitive to bradykinin and histamine-induced leakage of macromolecules.
    Svensjö E; Arfors KE
    Ups J Med Sci; 1979; 84(1):47-60. PubMed ID: 442278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of galactosamine induced edemas in the rat by drugs preventing macromolecular leakage from the hamster cheek pouch microvasculature.
    Perrissoud D; Broillet A; Ponard G
    Bibl Anat; 1979; (18):136-40. PubMed ID: 496813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.